![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, May 19, 2006 1:14:12 PM
Hi I actually stumbled across Biogenerics yesterday on a blog I read and was reading an old post promoting it. I have a few questions because I can't figure out things based on the companies website. 1.) Are they called Biogenerics because they took over a publicly traded shell in a reverse merger? Or do they just switch fields as the opportunity presents itself?
2.) Why did they do a forward split at such a low price before. I've been reading over the press releases and it makes no sense to me for a company trading at a dollar a share to do a 9 for 1 forward split. Could someone explain why that occurred.
3.) Finally for now. When they released that they projected this years EPS to be 8.5 cents was that prior to the split? Making eps about 1 cent a share?
Thanks. This could be a truly incredible opportunity, but doing critical dd is hard to track down on this company.
-Bigs
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM